Assembly Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 0.00 shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 585.29K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-20 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 0.00 shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 0.00 shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-09 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-12 | |
| 2019-12-31 | 585.29K shares 10-K · filed 2020-03-04 | |
| 2015-09-30 | 35.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2015-06-30 | 17.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | |
| 2015-03-31 | 23.20K shares 10-Q · filed 2015-05-08 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-14 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 0.00 shares 10-K · filed 2014-03-31 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 168.24K shares 10-K · filed 2014-03-31 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |